Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Blood flow improves through the stimulation of angiogenic growth factors
10.1016/j.jsbmb.2011.10.004 171
For Dihexa to progress in Alzheimer's research, several conditions would need to be met: Earlier intervention: Testing in cognitively normal individuals at high risk, or mild cognitive impairment, rather than established dementia Bioavailability optimization: Development of oral formulations with superior brain penetration, or better-tolerated intravenous regimens Combination approaches: Testing Dihexa alongside amyloid-targeting drugs or tau-focused therapeutics Mechanism refinement: Understanding which aspects of HGF signalling are beneficial versus which drive cancer risk concerns Patient stratification: Identifying subgroups (by genetics, biomarker status, disease stage) most likely to respond Dose optimization: The LIFT-AD trial used specific doses
However, there are varying results when it comes to weight loss, as some individuals see slower progress depending on their overall diet and exercise regimen
Liu J et al
US$ 29.01
US$ 21.04
US$ 22.92
US$ 29.21
US$ 25.47
US$ 21.87
US$ 27.50
